The Corona Virus was first started in the Wuhan city, China in December of 2019. It belongs to the Coronaviridae family, which can infect both animals and humans. The diagnosis of coronavirus disease-2019 (COVID-19) is typically detected by Serology, Genetic Real-Time reverse transcription–Polymerase Chain Reaction (RT-PCR), and Antigen testing. These testing methods have limitations like limited sensitivity, high cost, and long turn-around time. It is necessary to develop an automatic detection system for COVID-19 prediction. Chest X-ray is a lower-cost process in comparison to chest Computed tomography (CT). Deep learning is the best fruitful technique of machine learning, which provides useful investigation for learning and screening a large amount of chest X-ray images with COVID-19 and normal. There are many deep learning methods for prediction, but these methods have a few limitations like overfitting, misclassification, and false predictions for poor-quality chest X-rays. In order to overcome these limitations, the novel hybrid model called “Inception V3 with VGG16 (Visual Geometry Group)” is proposed for the prediction of COVID-19 using chest X-rays. It is a combination of two deep learning models, Inception V3 and VGG16 (IV3-VGG). To build the hybrid model, collected 243 images from the COVID-19 Radiography Database. Out of 243 X-rays, 121 are COVID-19 positive and 122 are normal images. The hybrid model is divided into two modules namely pre-processing and the IV3-VGG. In the dataset, some of the images with different sizes and different color intensities are identified and pre-processed. The second module i.e., IV3-VGG consists of four blocks. The first block is considered for VGG-16 and blocks 2 and 3 are considered for Inception V3 networks and final block 4 consists of four layers namely Avg pooling, dropout, fully connected, and Softmax layers. The experimental results show that the IV3-VGG model achieves the highest accuracy of 98% compared to the existing five prominent deep learning models such as Inception V3, VGG16, ResNet50, DenseNet121, and MobileNet.
Prediction of Stock price is now a day’s an existing and interesting research area in financial and academic sectors to know the scale of economies. There did not exists any significant set of rules to estimate and predict the scale of share in the stock exchange. Many evolutionary technologies are existing such as technical, fundamental, time, statistical and series analysis which help us to attempt the prediction process, but none of the methods are proved as reliable and accurate tool to the society in the estimation of stock exchange or share market scales. Here in this paper we attempted to do innovative work through Machine Learning approach to predict or sense the behaviour tracking of the stock market sensex. Linear regression, Support Vector regression, Decision Tree, Ramdom Forest Regressor and Extra Tree Regressor are the Machine Learning models implemented effectively in predicting the stock prices and define the activity between the exchanges the securities between the buyers and sellers. We predicted the price of the stock based on the closing value and stock price. An algorithm with high accuracy we do the process of comparison for the accuracy of each of the model and finally is considered as better algorithm for predicting stock price. As share market is a vague domain we cannot predict the conditions occur, and also share market can never be predicted, this job can be done easily and technically through this work and the main aim of this paper is to apply algorithms in Machine Learning in predicting the stock prices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.